Federal award (PURCHASE ORDER, fiscal year 2024)
Recipient: INTEGRATED DNA TECHNOLOGIES, INC.
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2025-03-27 to 2026-03-26
Current total value of award: $11940
Description: TWELVE (2) ANTISENSE OLIGONUCLEOTIDES (ASOS) FOR IN-VIVO NEURO TOX STUDY (COMMERCIAL PRODUCT, CUSTOMIZED)